Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: A position paper from the Italian Registry-Reference-Cited by-同舟云学术

Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: A position paper from the Italian Registry

Published:2010-09 Issue:9 Volume:42 Page:597-605
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Del Chiaro Marco,Zerbi Alessandro,Capurso Gabriele,Zamboni Giuseppe,Maisonneuve Patrick,Presciuttini Silvano,Arcidiacono Paolo Giorgio,Calculli Lucia,Falconi Massimo

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference122 articles.

1. Survival after resection for ductal adenocarcinoma of the pancreas;Sperti;Br J Surg,1996

2. Fatti e Cifre dei Tumori in Italia. 1a Edizione;Zanetti,1998

3. Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma;Del Chiaro;Pancreatology,2007

4. Tobacco and the risk of pancreatic cancer: a review and meta-analysis;Iodice;Langebecks Arch Surg,2008

5. Smoking cessation would substantially reduce the future incidence of pancreatic cancer in the European Union;Mulder;Eur J Gastroenterol Hepatol,2002

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age-period-cohort analysis of global, regional, and national pancreatic cancer incidence, mortality, and disability-adjusted life years, 1990–2019;BMC Cancer;2024-08-28

2. The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals;Familial Cancer;2024-03-16

3. Familial pancreatic cancer;Clinics and Research in Hepatology and Gastroenterology;2023-03

4. High signal intensity on diffusion-weighted magnetic resonance images is a useful finding for detecting early-stage pancreatic cancer;Abdominal Radiology;2021-07-05

5. Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper;ESMO Open;2021-06